Clinical trials
Not yet recruiting Phase 2 Adenocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 2 |
| National Cancer Institute (NCI) | 1 |
| Prof. Dr. Remi A. Nout | 1 |
| Prostate Cancer Clinical Trials Consortium | 1 |
| Qilu Pharmaceutical Co., Ltd. | 1 |
| Shanghai Chest Hospital | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
| University Health Network, Toronto | 1 |
| VA Office of Research and Development | 1 |
| West China Second University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 12 |
| Prostatic Neoplasms | 4 |
| Stomach Neoplasms | 3 |
| Carcinoma | 2 |
| Neoplasms | 2 |
| Neoplasms by Histologic Type | 2 |
| Neoplasms, Glandular and Epithelial | 2 |
| Esophageal Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Neoplastic Processes | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.